Comparing Q1 2025 with Q1 2026, global commercial hiring in life sciences shows relative stability, alongside shifts in the balance between permanent and contract placements. In Q1 2025, 77% of placements were permanent and 23% contract. This year, 62% are permanent and 33% contract, reflecting a modest rise in flexible staffing.

United Kingdom

Q1 2025 saw a record surge in UK commercial hiring, particularly in life sciences sales and marketing, with vacancies increasing by 18-21% year-on-year. Start-ups led the way, bringing commercial talent in earlier to demonstrate value to investors.

Entering 2026, the UK life sciences market continues to experience strong growth, but demand is now more evenly distributed across R&D, clinical, regulatory, and commercial functions. Commercial, sales, and BD hiring remains above Q1 2025 levels, though growth has moderated from last year’s spike. Roles are increasingly senior, strategic, and multi-functional, with greater scrutiny on ROI per hire.

Europe

Life sciences employment across Europe remains structurally robust. However, broader staffing trends show that agency and contingent hiring were uander pressure through 2023 and early 2024, leading to a more cautious but stabilising pattern by 2025.

In 2026, demand continues for commercial, market access, and go-to-market professionals, alongside a growing need for regulatory, compliance, and ESG expertise aligned with EU regulations. Compared to Q1 2025, commercial/BD hiring is modestly higher but more selective, with growth strongest in senior commercial, market access, and digitally fluent BD roles, while junior sales hiring remains relatively flat.

United States

The US life sciences workforce expanded significantly through 2024-2025, reaching approximately 2.1 million employees by March 2025, before a slight correction later in the year. This provides a strong base for 2026.

The market remains resilient, with steady demand across AI-driven R&D, digital health, and advanced manufacturing. Commercial, market access, and go-to-market functions are highlighted as high-growth areas. Compared to Q1 2025, US commercial/sales/BD hiring is slightly higher, but concentrated in senior BD, key account, and market access roles, while broad-based sales hiring has cooled after the 2024-25 uplift.

Key Takeaways

• Commercial, sales, and BD hiring continues to grow globally, but from a strong 2025 base, with more caution and selectivity.
• Growth is shifting towards senior commercial leaders (CBOs, VPs of BD, market access heads, strategic account roles) who can bridge science, digital, and commercial objectives.
• High-volume sales hiring is flatter or more scrutinised.
• Mid-level management and senior C-suite roles remain in high demand worldwide, yet recruitment processes are lengthening due to caution, and competition for experienced talent is intensifying.

Overall, the market is stabilising with selective growth, emphasising seniority, strategic impact, and cross-functional expertise over sheer volume.